摘要: Objective To analyze the impact of government subsidies on the R&D investment of pharmaceutical companies. Methods A two-way fixed-effect model was constructed by taking Chinese-listed pharmaceutical companies from 2012 to 2021 as research samples. Results and Conclusion Government subsidies have an incentive effect on enterprise R&D investment, and financial subsidies can effectively promote enterprise R&D investment.